Aflibercept for treating diabetic macular oedema

  • Technology appraisal guidance
  • TA346
  • Published: 

History

Macular oedema (diabetic) - aflibercept: equality impact assessment - guidance development

Macular oedema (diabetic) - aflibercept: final appraisal determination

Macular oedema (diabetic) - aflibercept: appraisal consultation

Macular oedema (diabetic) - aflibercept: final scope

Macular oedema (diabetic) - aflibercept: final matrix

Macular oedema (diabetic) - aflibercept: response to consultee and commentator comments on the draft scope and provisional matrix

Macular oedema (diabetic) - aflibercept: equality impact assessment - scoping

Macular oedema (diabetic) - aflibercept: draft scope for consultation (pre-referral) - January 2014

Macular oedema (diabetic) - aflibercept: provisional matrix (pre-referral) - January 2014